Piperidine, 3-(1-azetidinyl)-, (3S)-

Piperidine, 3-(1-azetidinyl)-, (3S)- Suppliers list
Company Name: Jiangsu yize medical technology co. LTD  
Tel: 18962082606
Email: 3394205705@qq.com
Products Intro: Product Name:(3S)-3-(1-Azetidinyl)piperidine
CAS:2284551-12-6
Purity:95% Package:1g;5g
Piperidine, 3-(1-azetidinyl)-, (3S)- Basic information
Product Name:Piperidine, 3-(1-azetidinyl)-, (3S)-
Synonyms:Piperidine, 3-(1-azetidinyl)-, (3S)-;(3S)-3-(1-Azetidinyl)piperidine
CAS:2284551-12-6
MF:C8H16N2
MW:140.23
EINECS:
Product Categories:
Mol File:2284551-12-6.mol
Piperidine, 3-(1-azetidinyl)-, (3S)- Structure
Piperidine, 3-(1-azetidinyl)-, (3S)- Chemical Properties
Boiling point 214.0±8.0 °C(Predicted)
density 1.014±0.06 g/cm3(Predicted)
pka10.28±0.20(Predicted)
Safety Information
MSDS Information
Piperidine, 3-(1-azetidinyl)-, (3S)- Usage And Synthesis
Piperidine, 3-(1-azetidinyl)-, (3S)- Preparation Products And Raw materials
Tag:Piperidine, 3-(1-azetidinyl)-, (3S)-(2284551-12-6) Related Product Information
Piperidine, 3-(1-azetidinyl)-4-fluoro-, (3S,4R)- Pyrrolidine, 3-(1-azetidinyl)-, hydrochloride (1:2) 3-Pyrrolidinol, 4-(1-azetidinyl)-, (3R,4R)- Piperidine, 3-(1-azetidinyl)-4-fluoro- Pyrrolidine, 4-(1-azetidinyl)-3,3-difluoro- Pyrrolidine, 3-(1-azetidinyl)-, (3S)- 4-Piperidinol, 3-(1-azetidinyl)-4-methyl- Piperidine, 3-(1-azetidinyl)-4-fluoro-, (3R,4S)-rel- 3-Pyrrolidinol, 4-(1-azetidinyl)-, (3R,4R)-rel- Pyrrolidine, 4-(1-azetidinyl)-3,3-difluoro-, (4S)- Piperidine, 3-(1-azetidinyl)-4,4-difluoro- Pyrrolidine, 3-(1-azetidinyl)-4-fluoro- 3-(1-Azetidinyl)pyrrolidine 3-(1-Azetidinyl)-pyrrolidine 2HCl

This site uses cookies
This website uses cookies and similar technologies to store and retrieve information about your use of this website. This information helps us to provide, analyse and improve our services, which may include personalised content or advertising. We may share this information with Google and other third parties. This cookies are necessary for our website to work properly . By clicking "Continue" or continuing to browse our site you are agreeing to our and our partners use of cookies.
Accept